HIGHLIGHTS
- who: Hon-Yi Lin and colleagues from the Department of Radiation Oncology, Dalin Tzu Hospital, Buddhist Tzu Medical Foundation, Taiwan have published the Article: Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer, in the Journal: (JOURNAL)
- what: This study aimed to investigate the correlation among the PADI2 expression level, the clinical-pathological factors, and the outcomes of BTC patients. Among the several isoforms of the PAD family, PADI2, the focus of the present study, is widely distributed across human organs, and its substrates are diverse . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.